Highlights
AMEX: CANF       Can-Fite Biopharma Ltd
Last Price Today's Change   Day's Range   Trading Volume
3.68   -0.19 (4.91%)  3.45 - 3.845  217,800

Overview

 
Avg Volume (4 weeks):794,936
4 Weeks Range:2.28 - 4.95
4 Weeks Price Volatility (%):
52.43%
52 Weeks Range:0.38 - 8.88
52 Weeks Price Volatility (%):
38.82%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Can Fite Biofarma Ltd is a clinical-stage biopharmaceutical company. The company is focused on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune inflammatory indications, oncology and liver diseases as well as sexual dysfunction. Its platform technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention. The company's pipeline drugs are synthetic, specific agonists and allosteric modulators targeting the A3AR. All drugs are orally bioavailable with an excellent safety profile.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers